Help
Add this page to your book
Show book (0 pages)
Suggest pagesColoplast
From Wikipedia, the free encyclopedia
 |
|
| Type | Publicly traded Aktieselskab |
|---|---|
| Traded as | OMX: COLO B |
| Industry | Health care |
| Founded | 1957 |
| Headquarters | Humlebæk, Denmark |
| Key people | Lars Rasmussen (President and CEO), Michael Pram Rasmussen (Chairman) |
| Products | Ostomy bags, continence products, dressings |
| Revenue | DKK 10.17 billion (2010/2011)[1] |
| Operating income | DKK 2.581 billion (2010/2011)[1] |
| Profit | DKK 1.819 billion (2010/2011)[1] |
| Total assets | DKK 9.218 billion (September 2011)[1] |
| Total equity | DKK 4.478 billion (September 2011)[1] |
| Employees | 7,330 (FTE, average 2010/2011)[1] |
| Website | www.coloplast.com |
Coloplast is an international company that develops, manufactures and markets medical devices and services related to ostomy, urology and continence, and wound treatment.
Coloplast was founded in 1957, employs more than 7,000 people and operates around the world.[2] It has its headquarters in Humlebæk, Denmark. Its U.S. headquarters is in Minneapolis, Minnesota.
[edit] External links
[edit] References
- ^ a b c d e f "Annual Report 2010/2011". Coloplast. http://www.coloplast.com/About/news/Documents/Annual%20report%202010-11.pdf. Retrieved 15 November 2011.
- ^ [1]
|
|
|||||
 |
This Danish corporation or company article is a stub. You can help Wikipedia by expanding it. |
